NVIV
NASDAQ
InVivo Therapeutics Holdings Corp
Overview
NVIV
Symbol
NASDAQ
Exchange
About stock

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Address: One Kendall Square, Cambridge, MA, United States, 02139

InVivo Therapeutics Holdings Corp dividend calculator
Report issue